Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
David Southwell Insider Profile
4 Followers
David Southwell, Director at Rocket Pharmaceuticals, holds 114.78K shares in Rocket Pharmaceuticals (Ticker: RCKT), holds ― shares in Spero Therapeutics (Ticker: SPRO), holds 14.50K shares in PTC Therapeutics (Ticker: PTCT).
David Southwell Rocket Pharmaceuticals (RCKT)Director
Rocket Pharmaceuticals (RCKT)
Director
Ranked #88,355 out of 98,624 Corporate Insiders
Profitable Transactions
1 out of 4 Profitable Transactions
Average Return
-42.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that David Southwell holds in companies
Most Profitable Insider Trade
The most profitable trade made by David Southwell
David Southwell's Trading History
Rocket Pharmaceuticals
Apr 16, 2024
Director
Uninformative Sell
1.95M
$2.52M
Spero Therapeutics
―
Director
―
―
TScan Therapeutics
May 20, 2022
CEO, Director
Informative Buy
89.70K
$1.26M
PTC Therapeutics
Feb 16, 2024
Director
Uninformative Buy
―
$414.26K
First Eagle Alternative Capital BDC
Dec 07, 2010
―
Informative Buy
157.28K
$174.79K
List of latest transactions for each holding click on a transaction to see David Southwell's performance on stock
You May Also Like
David Southwell insider profile FAQ
What is the percentage of profitable transactions made by David Southwell?
The percentage of profitable transactions made by David Southwell is 25%.
What is the average return per transaction made by David Southwell?
The average return per transaction made by David Southwell is -42.00%.
What stocks does David Southwell hold?
David Southwell holds: RCKT, SPRO, TCRX, PTCT, FCRD stocks.
What was David Southwell’s latest transaction?
David Southwell latest transaction was an Uninformative Sell of $1.95M.
What was David Southwell's most profitable transaction?
David Southwell’s most profitable transaction was an Informative Buy of TCRX stock on May 20, 2022. The return on the trade was 4.90%.
What is David Southwell's role in Rocket Pharmaceuticals?
David Southwell's role in Rocket Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.